Probiotic in treatment of pneumonia

Phase 3

• Conditions: Bacterial pneumonia.; Bacterial pneumonia, not elsewhere classified

• Registration Number: IRCT20200107046047N1
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Age over 12 years.
Bacterial pneumonia is early diagnosis.
Taking written consent from the patient to participate in the study.
The patient is able to eat probiotic or placebo.
Pneumonia is not very severe requiring admission in ICU.

Exclusion Criteria

The patient has no previous heart failure and pulmonary edema.
No underlying pulmonary disease.
Intolerance or allergy to probiotic.
Dissatisfaction of patients for participating in study.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of hospitalization. Timepoint: From hospitalization to discharge. Method of measurement: Number of days of hospitalization based on patient file and questionnaire.;Dyspnea duration. Timepoint: From hospitalization to discharge. Method of measurement: Completion of questionnaire and examination of patient.;Tachypnea duration. Timepoint: From hospitalization to discharge. Method of measurement: Completion of questionnaire and examination of patient.;Duration of cough. Timepoint: From hospitalization to discharge. Method of measurement: Completion of questionnaire and examination of patient.;Duration of lung auscultation rales. Timepoint: From hospitalization to discharge. Method of measurement: Patient examination and questionnaire completion.;Duration of fever. Timepoint: From hospitalization to discharge. Method of measurement: Patient examination and questionnaire completion.